The Right Heart in Patients with Cancer. A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
Kalliopi Keramida(National and Kapodistrian University of Athens), Giuseppe Rosano(Vita-Salute San Raffaele University), Yvonne Koop(Utrecht University), Antoni Bayés‐Genís(Universitat Autònoma de Barcelona), Amina Rakisheva(Almaty Management University), Thomas Thum(Medizinische Hochschule Hannover), Gerasimos Filippatos(National and Kapodistrian University of Athens), Pietro Ameri(Ospedale Policlinico San Martino), Sophie Van Linthout(Franklin University), Ana Barac(National Institute of Dental and Craniofacial Research), Jelena Čelutkienė, Daniel J. Lenihan(Saint Francis Medical Center), Susan Dent(Government of the United States of America), Andrew J.S. Coats(IRCCS Ospedale San Raffaele), Aaron L. Sverdlov(Hunter New England Local Health District), Marco Metra(GoHypersonic (United States)), Carlo G. Tocchetti(Federico II University Hospital), Teresa López‐Fernández(Hospital Universitario La Paz), Alexander R. Lyon(Royal Brompton Hospital), Valentina Mercurio, Riccardo Asteggiano, Yusuf Ziya Şener(State Hospital), Brenda Moura, Massimo Piepoli, Chiara Bucciarelli‐Ducci(University Hospitals Bristol NHS Foundation Trust), Joerg Hermann(Mayo Clinic in Arizona), Marijana Tadić(University Hospital Center Dr Dragiša Mišović), Thomas Suter, Peter van der Meer(University Medical Center Groningen), Jeroen J. Bax, Jutta Bergler Klein(Medical University of Vienna), Alain Cohen Solal(Inserm), Dimitrios Farmakis, Arjun K. Ghosh(Royal London Hospital)
Cited by 17
Related Papers
2016 European Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2016|6.5k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k